ARTICLEThis journal is Abstract: Four Cu(II) complexes, namely, [CuL 2 (SO 4 )(DMF)] n 1,[CuL 2 (CH 3 COO) 2 ] 2, [CuL 4 Cl 2 ]•2DMF•4H 2 O 3 and [CuL 4 (ClO 4 ) 2 ]4, (L=(RS)-1-(4-chloro-phenyl)-4,4-dimethyl-3-(1,2,4triazole-1-ylmethyl)pentan-3-ol), tebuconazole) have been synthesized, then their structures were identified by elemental analysis (EA), infrared spectra (IR) and single crystal X-ray diffraction (XRD). Moreover, the four obtained complexes were screened for antifungal activities against four selected fungi using mycelial growth rate method. The structural analysis indicates that the different coordination modes of the ligands and counter anions contribute to a one-dimensional polymer chain structure in complex 1 and zero-dimensional mononuclear structures in complex 2-4. The results of the antifungal activities show that all the complexes synthesized show better antifungal activities than the ligand L. In addition, the mechanism of the increased antifungal activities of the title complexes in comparison with the ligand was discussed preliminarily and the synergistic interaction between Cu 2+ and tebuconazole was also investigated by the Wadley approach.In an earlier study, we have reported two Cu(II)complexes of triadimefon and found that the copper complexes exhibited potent antifungal activity toward Gibberella nicotiancola, Gibberella saubinetii, Alternaria solani, Physalospora berengeriana, and Glomerella cingulata. 21 To continue our work on the complexes of